Mersen (MRN) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
15 Nov, 2025Opening remarks and agenda
The meeting was opened on May 16, 2025, with live streaming and replay available; legal formalities and quorum (64.02% of voting rights) were confirmed.
The agenda included a review of 2024 results, market perspectives, auditor reports, board activities, committee summaries, Q&A, and voting on resolutions.
Financial performance review
2024 saw record revenue of €1.244 billion, with 10% average annual growth since 2020; North America led growth (+6.3%), while Asia saw a decline due to solar market slowdown.
EBITDA reached €206 million, a new record, with a margin of 16.5%; operating income before non-recurring items was €131.1 million (10.5% of sales).
Net income fell to €61.5 million, mainly due to non-recurring charges, adaptation plan costs, and higher financial expenses.
Strong operational cash flow (€194 million) and high investments (€204 million) led to increased net debt (€370 million), partly due to acquisitions; leverage remains solid at 1.8.
Extra-financial performance improved: 14% CO2 reduction (scopes 1 & 2), better supplier compliance, and increased gender diversity in management.
Board and executive committee updates
The board has eight members, including independent and employee representatives; two mandates were up for renewal, with one extended for only one year to allow for succession planning.
The executive committee expanded to 11 members, with a new Deputy CEO appointed as part of succession planning for the CEO role, to be finalized by mid-2025.
CEO compensation: fixed at €500,000, variable at €359,050 (down 50% YoY), and 17,321 performance shares; 2025 policy increases EBITDA weighting in variable pay.
Latest events from Mersen
- Resilient 2025 with €1,186m sales, 16% EBITDA margin, and positive cash flow; growth ahead.MRN
H2 202518 Mar 2026 - Record sales and 10.5% margin, led by transport and North America; solar, SiC to slow.MRN
Q4 2024 TU3 Feb 2026 - Medium-term financial targets postponed to 2029 amid sector delays and cost-saving initiatives.MRN
CMD 20243 Feb 2026 - Record sales and robust cash flow in 2024; 2025 outlook stable amid sector headwinds.MRN
H2 20243 Feb 2026 - 2025 sales fell 3.2% organically, but margins and capex guidance were maintained.MRN
Q4 2025 TU3 Feb 2026 - Record H1 sales and margin growth, with US expansion and 2024 guidance confirmed.MRN
H1 20242 Feb 2026 - Q3 growth slowed to 1.2% amid solar and semiconductor weakness; 2024 guidance revised down.MRN
Q3 2024 TU19 Jan 2026 - Q1 2025 sales fell 2.5% to €305m as solar and SiC slumped, but wind and rail grew strongly.MRN
Q1 2025 TU23 Dec 2025 - H1 2025: Sales down, but margins, cash flow, and guidance held firm; leverage at 2.2x.MRN
H1 202516 Nov 2025